Saturday, July 19, 2025 4:53:59 PM
No outstanding share increase for one month? That is hard to believe
but if true could perhaps indicate that together with funds at NWBO's disposal,
the recent $ 3.9M loan was intended to carry NWBO until approval without
further share dilution.
Could approval become reality within a month after July 23 (SI 2025 No.87)?
AI Overview
"As of July 15, 2025, Northwest Biotherapeutics (NWBO) had approximately 1.44 billion shares outstanding.
Additional details on NWBO's shares outstanding:
The number of outstanding shares can change due to events like stock splits or buybacks.
Data from June 25th, 2025, also indicates 1.44B shares outstanding.
The number of shares has increased by 9.38% year-to-date in 2025.
Over the past year, the number of shares increased by 11.99%.
Insider ownership accounts for 7.42% of outstanding shares.
Institutional ownership is 0.05% of outstanding shares.
The remaining 92.53% of shares are held by the public and other investors.
The public float (shares available for public trading) is 1.34B"
but if true could perhaps indicate that together with funds at NWBO's disposal,
the recent $ 3.9M loan was intended to carry NWBO until approval without
further share dilution.
Could approval become reality within a month after July 23 (SI 2025 No.87)?
AI Overview
"As of July 15, 2025, Northwest Biotherapeutics (NWBO) had approximately 1.44 billion shares outstanding.
Additional details on NWBO's shares outstanding:
The number of outstanding shares can change due to events like stock splits or buybacks.
Data from June 25th, 2025, also indicates 1.44B shares outstanding.
The number of shares has increased by 9.38% year-to-date in 2025.
Over the past year, the number of shares increased by 11.99%.
Insider ownership accounts for 7.42% of outstanding shares.
Institutional ownership is 0.05% of outstanding shares.
The remaining 92.53% of shares are held by the public and other investors.
The public float (shares available for public trading) is 1.34B"
Bullish
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
